Related Experiment Video
Updated: May 17, 2026

Isolation of Neonatal Extrahepatic Cholangiocytes
Published on: June 5, 2014
Neonatal intrahepatic cholestasis caused by citrin deficiency: prevalence and SLC25A13 mutations among Thai infants
Suporn Treepongkaruna1, Suttiruk Jitraruch, Porawee Kodcharin
1Department of Pediatrics, Faculty of Medicine Ramathibodi Hospital, Mahidol University, Bangkok, 10400, Thailand.
Insights
Neonatal intrahepatic cholestasis caused by citrin deficiency (NICCD) is often misdiagnosed. This study found NICCD in 12.8% of Thai infants with idiopathic cholestatic jaundice, suggesting it should be considered in diagnosis.
Area of Science:
- Genetics and Molecular Biology
- Pediatric Gastroenterology
- Metabolic Disorders
Background:
- Idiopathic neonatal hepatitis (INH) and biliary atresia are common causes of infant cholestatic jaundice.
- Neonatal intrahepatic cholestasis caused by citrin deficiency (NICCD), linked to SLC25A13 gene mutations, is increasingly identified, particularly in East Asian populations.
- NICCD is often misdiagnosed as INH due to spontaneous recovery, complicating prevalence assessment.
Purpose of the Study:
- To determine the prevalence of NICCD and SLC25A13 mutations in Thai infants.
- To compare clinical and biochemical characteristics of NICCD and non-NICCD infants.
- To investigate the genetic basis of NICCD in a Thai cohort.
Main Methods:
- Enrolled infants with idiopathic cholestatic jaundice or INH.
- Reviewed clinical and biochemical data, including urine organic acid and plasma amino acid profiles.
- Performed PCR-sequencing of all 18 exons of the SLC25A13 gene and gap PCR for specific mutations.
Main Results:
- NICCD was identified in 5 out of 39 (12.8%) infants, with common mutations including 851del4.
- NICCD patients presented with higher alkaline phosphatase (ALP), alpha-fetoprotein (AFP), and lower alanine aminotransferase (ALT) compared to non-NICCD infants.
- NICCD infants showed elevated citrulline levels and threonine/serine ratios, with jaundice resolving in all NICCD cases.
Conclusions:
- NICCD is a significant consideration for infants presenting with idiopathic cholestasis.
- The estimated prevalence of NICCD in Thai infants is 1/48,228, with a carrier rate of 1/110.
- Further research with larger populations is needed to confirm the true prevalence of NICCD and AGC2 deficiency.
Background:
The most common causes of cholestatic jaundice are biliary atresia and idiopathic neonatal hepatitis (INH). Specific disorders underlying INH, such as various infectious and metabolic causes, including neonatal intrahepatic cholestasis caused by citrin deficiency (NICCD) especially, in East Asian populations are increasingly being identified. Since most NICCD infants recovered from liver disease by 1 year of age, they often are misdiagnosed with INH, leading to difficulty in determining the true prevalence of NICCD. Mutation(s) of human SLC25A13 gene encoding a mitochondrial aspartate/glutamate carrier isoform 2 (AGC2), can lead to AGC2 deficiency, resulting in NICCD and an adult-onset fatal disease namely citrullinemia type II (CTLN2). To study the prevalence of NICCD and SLC25A13 mutations in Thai infants, and to compare manifestations of NICCD and non-NICCD, infants with idiopathic cholestatic jaundice or INH were enrolled. Clinical and biochemical data were reviewed. Urine organic acid and plasma amino acids profiles were analyzed. PCR-sequencing of all 18 exons of SLC25A13 and gap PCR for the mutations IVS16ins3kb and Ex16+74_IVS17-32del516 were performed. mRNA were analyzed in selected cases with possible splicing error.
Results:
Five out of 39 (12.8%) unrelated infants enrolled in the study were found to have NICCD, of which three had homozygous 851del4 (GTATdel) and two compound heterozygous 851del4/IVS16ins3kb and 851del4/1638ins23, respectively. Two missense mutations (p.M1? and p.R605Q) of unknown functional significance were identified. At the initial presentation, NICCD patients had higher levels of alkaline phosphatase (ALP) and alpha-fetoprotein (AFP) and lower level of alanine aminotransferase (ALT) than those in non-NICCD patients (p< 0.05). NICCD patients showed higher citrulline level and threonine/serine ratio than non-NICCD infants (p< 0.05). Fatty liver was found in 2 NICCD patients. Jaundice resolved in all NICCD and in 87.5% of non-NICCD infants at the median age of 9.5 and 4.0 months, respectively.
Conclusion:
NICCD should be considered in infants with idiopathic cholestasis. The preliminary estimated prevalence of NICCD was calculated to be 1/48,228 with carrier rate of 1/110 among Thai infants. However, this number may be underestimated and required further analysis with mutation screening in larger control population to establish the true prevalence of NICCD and AGC2 deficiency.
Related Concept Videos
Inborn Errors of Metabolism
Jaundice
Chronic Pancreatitis I: Introduction
Pharmacokinetics in Pediatric Patients: Drug Metabolism
Protein Import into the Peroxisomes
Peroxisomal Protein Import:
Peroxisomes lack the genetic machinery required to code for their own proteins. Hence, most peroxisomal membrane, lumenal and transmembrane proteins are synthesized in the cytoplasm or ER and transported to the peroxisome...
Animal Mitochondrial Genetics
